Azintuxizumab vedotin

Azintuxizumab vedotin Uses, Dosage, Side Effects, Food Interaction and all others data.

Azintuxizumab vedotin is under investigation in clinical trial NCT02951117 (A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment).

Trade Name Azintuxizumab vedotin
Generic Azintuxizumab vedotin
Azintuxizumab vedotin Other Names Azintuxizumab vedotin
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Azintuxizumab vedotin
Azintuxizumab vedotin

Innovators Monograph

You find simplified version here Azintuxizumab vedotin


*** Taking medicines without doctor's advice can cause long-term problems.
Share